Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02776566 · ClinicalTrials.gov registry record · NA

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

A NA study of Cardiovascular Disease and Vascular Disease, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
86
Enrollment target
1
Study location

NCT02776566: Completed NA study of Cardiovascular Disease and Vascular Disease, sponsored by University of Illinois at Chicago.

NCT02776566 is a NA study of Cardiovascular Disease and Vascular Disease that has completed, run by University of Illinois at Chicago. The registered enrollment target is 86 participants, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02776566, a NA study of Cardiovascular Disease and Vascular Disease, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to demonstrate the feasibility and effectiveness of anticoagulation self-monitoring coupled with an educational intervention in a minority underserved population.

Primary Outcome

TTR will be calculated for each patient using the linear interpolation method. This method has been associated with clinical outcomes such as risk for thromboembolic events, and thus was selected over other methods of expressing the TTR such as fraction of International Normalized Ratio (INR) in range and cross-section of files

Interventions

  • OTHER Patient Self-Monitoring vs Anticoagulation Clinic

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2016-01
Est. Completion 2019-02
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT02776566 record still lists

NCT02776566 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (97% lower).

The record links to 4 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Patient Self-Monitoring vs Anticoagulation Clinic is the first listed.

NCT02776566 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT02776566 about?

NCT02776566 is a clinical study titled "Patient-Centered Anticoagulation Self-Monitoring in Minority Patients". The purpose of this study is to demonstrate the feasibility and effectiveness of anticoagulation self-monitoring coupled with an educational intervention in a minority underserved population.

What is the current status of trial NCT02776566?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2016-01. Estimated completion is 2019-02.

What conditions does trial NCT02776566 study?

This clinical trial studies the following conditions: Cardiovascular Disease, Vascular Disease, Thromboembolism, Blood Coagulation Disorders.

What interventions are being tested in trial NCT02776566?

The interventions under investigation include: Patient Self-Monitoring vs Anticoagulation Clinic (OTHER).

Who is sponsoring clinical trial NCT02776566?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02776566 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02776566's enrollment target sits among peer trials

86 85th of 137 higher than 53 of 137 other Cardiovascular Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01639508 · 86 participants · Phase 2

    Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity

  • NCT03519269 · 86 participants · NA

    Navio Robotic Versus Conventional Total Knee Arthroplasty

  • NCT04132999 · 86 participants · NA

    PAP for Children With DS and OSAS

  • NCT04545957 · 86 participants · NA

    Jump: MR Simulation For Radiation Therapy Master Protocol

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02776566, the US trial registry maintained by the National Library of Medicine. NCT02776566 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.